youtube_live
Q3 2026 earnings • released • EPS beat +8,62% • Revenue beat +2,31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
102,14 US$
arrow_upward
+1,31%(+1,32) 1D
102,14 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 6 ნოე, 16:00:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
99,00 US$
High
102,19 US$
Low
98,50 US$
Mkt. cap
58,87 მლრდ.
Avg. vol.
4,32 მლნ.
Volume
5,11 მლნ.
P/E ratio
57,91
52-wk high
104,16 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
Open
99,00 US$
High
102,19 US$
Low
98,50 US$
Mkt. cap
58,87 მლრდ.
Avg. vol.
4,32 მლნ.
Volume
5,11 მლნ.
P/E ratio
57,91
52-wk high
104,16 US$
52-wk low
74,66 US$
EPS
1,76 US$
Beta
0,85
Shares outstanding
575,00 მლნ.
No. of employees
16 ათ.
News stories
From web sources and news partners
News Corp
·
11 საათის წინ
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Zacks
·
16 საათის წინ
HIMS' Q3 Earnings: Can Weight Loss Momentum Drive Performance?
Trefis
·
22 საათის წინ
Is Edwards Lifesciences Stock Really Expensive?
TradingView
·
1 დღის წინ
Key facts: EW beats, lifts view; TAVR meets goals; stock hits 2022 high
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ათ.
Founded1958
Headquartersირვაინი, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryMedical device
Websiteedwards.com